- Home
- TAOP vs PRFX Comparison
TAOP vs PRFX Comparison
Compare TAOP & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- PRFX
- Stock Information
- Founded
- TAOP 1993
- PRFX 2007
- Country
- TAOP China
- PRFX Israel
- Employees
- TAOP N/A
- PRFX N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- PRFX Health Care
- Exchange
- TAOP Nasdaq
- PRFX Nasdaq
- Market Cap
- TAOP 2.9M
- PRFX 2.8M
- IPO Year
- TAOP N/A
- PRFX 2020
- Fundamental
- Price
- TAOP $2.62
- PRFX $1.26
- Analyst Decision
- TAOP
- PRFX Hold
- Analyst Count
- TAOP 0
- PRFX 1
- Target Price
- TAOP N/A
- PRFX N/A
- AVG Volume (30 Days)
- TAOP 350.3K
- PRFX 159.3K
- Earning Date
- TAOP 12-08-2025
- PRFX 11-14-2025
- Dividend Yield
- TAOP N/A
- PRFX N/A
- EPS Growth
- TAOP N/A
- PRFX N/A
- EPS
- TAOP N/A
- PRFX N/A
- Revenue
- TAOP $36,196,786.00
- PRFX N/A
- Revenue This Year
- TAOP N/A
- PRFX N/A
- Revenue Next Year
- TAOP N/A
- PRFX N/A
- P/E Ratio
- TAOP N/A
- PRFX N/A
- Revenue Growth
- TAOP N/A
- PRFX N/A
- 52 Week Low
- TAOP $1.81
- PRFX $1.20
- 52 Week High
- TAOP $24.75
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- TAOP 43.84
- PRFX 48.17
- Support Level
- TAOP $1.81
- PRFX $1.20
- Resistance Level
- TAOP $2.80
- PRFX $1.29
- Average True Range (ATR)
- TAOP 0.29
- PRFX 0.09
- MACD
- TAOP -0.01
- PRFX -0.00
- Stochastic Oscillator
- TAOP 50.94
- PRFX 41.50
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.